Related Experiment Videos
Antineoplastic agents, 177. Isolation and structure of phyllanthostatin 6
G R Pettit1, D E Schaufelberger, R A Nieman
1Cancer Research Institute, Arizona State University, Tempe 85287-1604.
Journal of Natural Products
|November 1, 1990
Summary
A new Phyllanthus glycoside, phyllanthostatin 6, was isolated from Phyllanthus acuminatus roots. This compound demonstrated significant inhibition of murine lymphocytic leukemia cell growth.
Area of Science:
- Phytochemistry
- Pharmacology
- Natural Products Chemistry
Background:
- Phyllanthus species are a source of bioactive compounds.
- Previous research indicates potential anticancer properties of Phyllanthus glycosides.
Purpose of the Study:
- To isolate and characterize new glycosides from Phyllanthus acuminatus.
- To evaluate the cytotoxic activity of isolated compounds against a leukemia cell line.
- To develop improved isolation methods for key constituents.
Main Methods:
- Isolation of glycosides from plant roots using chromatography.
- Structural elucidation using high-resolution fast atom bombardment mass spectrometry (HRFABMS) and 2D-nuclear magnetic resonance (2D-NMR) spectroscopy.
- High-performance liquid chromatography (HPLC) for separation and analysis.
Main Results:
- Isolation and structural determination of phyllanthostatin 6, didesacetylphyllanthostatin 3, and descinnamoylphyllanthocindiol.
- Phyllanthostatin 6 exhibited potent inhibition of the P-388 lymphocytic leukemia cell line (ED50 = 0.35 µg/ml).
- An optimized HPLC separation technique and a new isolation procedure for phyllanthoside were developed.
Conclusions:
- Phyllanthus acuminatus yields novel glycosides with significant cytotoxic activity.
- Phyllanthostatin 6 is a promising candidate for further anticancer research.
- The developed isolation and separation techniques enhance the study of Phyllanthus constituents.